相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma
Tianyi Liu et al.
CANCER RESEARCH (2022)
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma
Ilona Berestjuk et al.
EMBO MOLECULAR MEDICINE (2022)
Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells
Takashi Yahata et al.
HAEMATOLOGICA (2021)
Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas
Vadim Lincoln et al.
EXPERIMENTAL DERMATOLOGY (2021)
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu et al.
NATURE MEDICINE (2021)
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53
Kaiji Fan et al.
ONCOGENE (2021)
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy
Mario Del Rosso et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Plasminogen Activator Inhibitor-1 Secretion by Autophagy Contributes to Melanoma Resistance to Chemotherapy through Tumor Microenvironment Modulation
Hong-Tai Tzeng et al.
CANCERS (2021)
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
Taku Fujimura et al.
PHARMACEUTICS (2021)
The Tumor Microenvironment in SCC: Mechanisms and Therapeutic Opportunities
Nadia Ghinelli Amor et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma
Syed Jafar Mehdi et al.
BMC CANCER (2021)
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape
Veronica Romano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients
Kentaro Ohuchi et al.
FRONTIERS IN ONCOLOGY (2021)
Inhibition of PAI-1 Blocks PD-L1 Endocytosis and Improves the Response of Melanoma Cells to Immune Checkpoint Blockade
Yu-Ju Tseng et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study
Alexander J. Stratigos et al.
LANCET ONCOLOGY (2021)
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
S. P. D'Angelo et al.
ESMO OPEN (2021)
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
Michael J. Wagner et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study
Michael S. Khodadoust et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
Maria Grazia Atzori et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19
T. Fujimura et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
Michael R. Migden et al.
LANCET ONCOLOGY (2020)
B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2
Hideki Yoshida et al.
SCIENTIFIC REPORTS (2020)
Successful treatment of unresectable recurrent cutaneous squamous cell carcinoma of the scalp with meningeal invasion with nivolumab monotherapy
Taku Fujimura et al.
DERMATOLOGIC THERAPY (2020)
Increased expression of dermal LL37 may trigger migration of CCR7+regulatory T cells in extramammary Paget's disease
Chunbing Lyu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
Y. Nakamura et al.
ANNALS OF ONCOLOGY (2020)
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Danny Rischin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers
Taku Fujimura et al.
BIOMOLECULES (2020)
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanoma
Taku Fujimura et al.
MELANOMA RESEARCH (2020)
Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study
Anton Ilich et al.
THROMBOSIS RESEARCH (2020)
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma
Yota Sato et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment of Advanced Melanoma: Past, Present and Future
Taku Fujimura et al.
LIFE-BASEL (2020)
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells
Clara Gomez-Aleza et al.
NATURE COMMUNICATIONS (2020)
Anti-PD-1 antibody therapy for epithelial skin malignancies An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)
Maki Ishii et al.
MEDICINE (2020)
Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5
Ziqian Li et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Accumulation of exhausted CD8+T cells in extramammary Paget's disease
Natsuko Iga et al.
PLOS ONE (2019)
Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer
Taisuke Yagi et al.
EUROPEAN JOURNAL OF CANCER (2019)
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease
Yota Sato et al.
EXPERIMENTAL DERMATOLOGY (2019)
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases
Yenny Angela et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors
Taku Fujimura et al.
EXPERIMENTAL DERMATOLOGY (2019)
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy updates outcome in metastatic melanoma
Pok Fai Wong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
Kayo Tanita et al.
FRONTIERS IN ONCOLOGY (2019)
TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1
Yuan Tian et al.
AGING-US (2019)
Periostin Links Skin Inflammation to Melanoma Progression in Humans and Mice
Fumitaka Ohno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma
Taku Fujimura et al.
FRONTIERS IN MEDICINE (2019)
Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
Yumi Kambayashi et al.
FRONTIERS IN MEDICINE (2019)
Merkel cell carcinomas infiltrated with CD33= myeloid cells and CD8+ T cells are associated with improved outcome
Thibault Kervarrec et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study
Taku Fujimura et al.
Oncotarget (2018)
ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate
Nádia Ghinelli Amôr et al.
Oncotarget (2018)
Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells
Maria Rita Gaiser et al.
ONCOIMMUNOLOGY (2018)
An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer
Alexander Liede et al.
ONCOIMMUNOLOGY (2018)
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
Taku Fujimura et al.
FRONTIERS IN ONCOLOGY (2018)
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
Matteo S. Carlino et al.
EUROPEAN JOURNAL OF CANCER (2018)
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Christian U. Blank et al.
NATURE MEDICINE (2018)
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma
Taku Fujimura et al.
FRONTIERS IN ONCOLOGY (2018)
Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient
Taku Fujimura et al.
JOURNAL OF DERMATOLOGY (2017)
Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma
Yuki Honda et al.
ONCOIMMUNOLOGY (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin
Silje Haukali Omland et al.
BMC CANCER (2017)
Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas
K. A. Rubina et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma
Taku Fujimura et al.
ANTICANCER RESEARCH (2017)
The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides
Sadanori Furudate et al.
EXPERIMENTAL DERMATOLOGY (2016)
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
Blanca Homet Moreno et al.
ONCOIMMUNOLOGY (2016)
Periostin as a multifunctional modulator of the wound healing response
John T. Walker et al.
CELL AND TISSUE RESEARCH (2016)
RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease
Taku Fujimura et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma
Sadanori Furudate et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity
Taku Fujimura et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck
Hamideh Kadeh et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Neutrophils in the Tumor Microenvironment
Davalyn R. Powell et al.
TRENDS IN IMMUNOLOGY (2016)
The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
Ivan V. Litvinov et al.
CLINICAL CANCER RESEARCH (2015)
A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis
Ling Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+M2 Macrophages
Taku Fujimura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages
Yumi Kambayashi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
Neutrophils in Cancer: Two Sides of the Same Coin
Eileen Uribe-Querol et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Periostin Is a Key Niche Component for Wound Metastasis of Melanoma
Keitaro Fukuda et al.
PLOS ONE (2015)
Plasminogen activator inhibitor-1 regulates infiltration of macrophages into melanoma via phosphorylation of FAK-Tyr925
Bikash Thapa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin
S. Kale et al.
ONCOGENE (2014)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Comparison of Foxp3+ Regulatory T cells and CD163+ Macrophages in Invasive and Non-invasive Extramammary Paget's Disease
Taku Fujimura et al.
ACTA DERMATO-VENEREOLOGICA (2012)
SERPINE1 expression discriminates site-specific metastasis in human melanoma
R. Matthew Klein et al.
EXPERIMENTAL DERMATOLOGY (2012)
Association of the numbers of CD163+ cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma
Makoto Sugaya et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Inflammatory events during murine squamous cell carcinoma development
Thais Helena Gasparoto et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
Taku Fujimura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages
Nina Linde et al.
JOURNAL OF PATHOLOGY (2012)
Merkel cell carcinoma induces lymphatic microvessel formation
Siegfried Werchau et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Plasminogen Activator Inhibitor-1 Controls Bone Marrow-Derived Cells Therapeutic Effect Through MMP9 Signaling: Role in Physiological and Pathological Wound Healing
Teni G. Ebrahimian et al.
STEM CELLS (2012)
Identification of a novel cell binding site of periostin involved in tumour growth
Paola Orecchia et al.
EUROPEAN JOURNAL OF CANCER (2011)
Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated
Julia S. Pettersen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma
Ryosuke Hino et al.
CANCER (2010)
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Hanne Van Gorp et al.
MOLECULAR IMMUNOLOGY (2010)
Perilesional treatment of metastatic melanoma with interferon-β
T. Fujimura et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction
Jeng-Wei Tjiu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma
Jennifer Freytag et al.
JOURNAL OF ONCOLOGY (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
PAI-1 is a critical upstream regulator of the TGF-beta 1/EGF-induced invasive phenotype in mutant p53 human cutaneous squamous cell carcinoma
Cynthia E. Wilkins-Port et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2007)
分享论文
